Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:
Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)
Genome Medicine is calling for submissions to a new Collection on Tumor immune contexture in cancer progression and treatment guest edited by Noel De Miranda. Deadline 15 June 2024
Genome Medicine is calling for submissions to a Collection on genome instability in cancer and cancer therapy, guest edited by Timothy Yap and Christopher Lord. Deadline 2 October 2023
Submission deadline has been extended to 1 December 2023 for our Cardiovascular disease Collection guest edited by James Ware and Connie Bezzina.
A special focus on the latest advances on neuro-immune interactions in the brain, guest edited by Philip de Jager and Carlos Cruchaga.
Read the latest Research and and Reviews on the human microbiome in health and disease:
Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides
Langdon, A., Schwartz, D.J., Bulow, C. et al. Genome Med 13, 28 (2021)
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Hayase, E., Jenq, R.R. Genome Med 13, 107 (2021)
Strain-level epidemiology of microbial communities and the human microbiome
Yan, Y., Nguyen, L.H., Franzosa, E.A. et al. Genome Med 12, 71 (2020).
Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma
Usyk, M., Pandey, A., Hayes, R.B. et al. Genome Med 13, 160 (2021).
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, cardiology, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
The impact of genomics on precision public health
Guest editors: Muin Khoury and Kathryn Holt
Translating the microbiome in health and disease
Guest editor: Ramnik Xavier
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
A decade of Genome Medicine
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
From genome integrity to cancer
Guest editor: Serena Nik-Zainal
This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here.
The following summary describes the peer review process for this journal:
We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.
11 September 2023
C19 Rapid Review initiative
Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here.
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.
2022 Citation Impact
12.3 - 2-year Impact Factor
13.8 - 5-year Impact Factor
2.422 - SNIP (Source Normalized Impact per Paper)
4.851 - SJR (SCImago Journal Rank)
64 days submission to first editorial decision for all manuscripts (Median)
212 days submission to accept (Median)
14,220 Altmetric mentions